These stocks should outperform as the Iran deal is finalized, says UBS

With a deal on the horizon, UBS thinks that stocks like Southwest Airlines and Eastman Chemicals could benefit from a potential settlement.

Skip NavigationJoin ICJoin ProLivestreamMenuWith the end of the Middle East war in sight, UBS thinks that stocks like Southwest Airlines and Eastman Chemical could be beneficiaries of a potential settlement between the U.S. and Iran. Earlier this week, the U.S. and Iran reached a deal to end the war in the Middle East. Both sides have agreed to a “memorandum of understanding” and have decided to cease military operations, with an official signing ceremony to take place in Switzerland this Friday. With this deal on the horizon, UBS shared a list of U.S. stocks that could potentially benefit and outperform on a Middle East resolution. “These stocks have a negative score on our qualitative framework (i.e. most negatively impacted by the conflict), have underperformed since 27/2, are Buy-rated, cheap on [price earnings] relative to the market against their norms and not crowded,” the bank wrote in a note to clients. Select names from UBS’ basket are shown below. These names, the bank wrote, “are less crowded than MSCI U.S., and hence may be more likely to outperform.” UBS identified Southwest Airlines as a possible beneficiary. In a Tuesday note, analysts from Jefferies were similarly optimistic on the stock. While the bank currently has a hold rating on the name, it hiked its price target to $44 from $37. Analyst Sheila Kahyaoglu said her team recently met with Southwest leadership. “Mgmt notes it is increasingly confident that the backdrop of sticky fare increases, industry discipline & exits, and stable-ish fuel supports the ability to achieve > $4/sh of EPS in ’26 if demand remains resilient into off-peak,” she said. Shares of Southwest Airlines are up 15% this year. Another name on the list was Eastman Chemical. In April, JPMorgan upgraded the chemical products manufacturer to an overweight rating from neutral. Analyst Jeffrey Zekauskas also lifted his price target to $80 per share from $70. Shares of Eastman Chemical have added almost 15% in 2026. Zekauskas’ updated forecast implies a jump of 6% from here. “We think that Eastman is a good risk/reward vehicle on a total return basis. We expect Eastman’s earnings to experience a positive turn in 2026,” the analyst wrote. “We think the company should benefit from higher commodity earnings in the near-term and from a recovery in durable goods manufacturing over a longer term.”Read More

About The Author

Leave a Reply

Your email address will not be published. Required fields are marked *

About the Author

Easy WordPress Websites Builder: Versatile Demos for Blogs, News, eCommerce and More – One-Click Import, No Coding! 1000+ Ready-made Templates for Stunning Newspaper, Magazine, Blog, and Publishing Websites.

BlockSpare — News, Magazine and Blog Addons for (Gutenberg) Block Editor

Search the Archives

Access over the years of investigative journalism and breaking reports